TITLE

Montelukast and Churg-Strauss syndrome

AUTHOR(S)
Solans, R.; Bosch, J. A.; Selva, A.; Orriols, R.; Vilardell, M.
PUB. DATE
February 2002
SOURCE
Thorax;Feb2002, Vol. 57 Issue 2, p183
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Several cases of eosinophilic conditions including Churg- Strauss syndrome (CSS) hove recently been reported in asthmatic patients being treated with antileukotriene receptor antagonists. One patient with CSS who experienced clinical relapse after treatment with montelukast and two asthmatic patients who developed CSS while receiving montelukast treatment are described. In one case reduction in the dose of oral steroid preceded the onset of CSS. To our knowledge, no case of CSS relapse has previously been reported in association with leukotriene antagonists.
ACCESSION #
12998487

 

Related Articles

  • Churg-Strauss syndrome associated with montelukast. Mukhopadhyay, A.; Stanley, N. N. // Postgraduate Medical Journal;Jun2001, Vol. 77 Issue 908, p390 

    Churg-Strauss syndrome (CSS) has recently been reported in patients with asthma receiving leukotriene receptor antagonists (LTRA5). In this paper a case of CSS after treatment with montelukast is described. As in other LTRA treated cases, prior withdrawal of maintenance oral steroid may have...

  • Montelukast.  // Reactions Weekly;6/6/2009, Issue 1255, p25 

    The article cites a study on the association between Churg-Strauss syndrome and montelukast, a leukotriene receptor antagonist.

  • A Purpuric Rash and Mononeuritis Multiplex. Winchester, David E.; Guilliams, Kristin // American Family Physician;2/15/2008, Vol. 77 Issue 4, p501 

    A quiz about purpuric rash and mononeuritis multiplex is presented.

  • Leukotriene Modifiers and Churg-Strauss Syndrome: Adverse Effect or Response to Corticosteroid Withdrawal? Wechsler, M.E.; Pauwels, R.; Drazen, J.M. // Drug Safety;Oct1999, Vol. 21 Issue 4, p241 

    Zafirlukast, montelukast and pranlukast are all cysteinyl leukotriene receptor antagonists that have recently been approved for the treatment of asthma. Within 6 months of zafirlukast being made available on the market, 8 patients who received the agent for moderate to severe asthma developed...

  • Deposition of eosinophil cationic protein in granulomas in allergic granulomatosis and vasculitis: the Churg-Strauss syndrome. Po-Chin Tai; Holt, Mary E.; Denny, Paul; Gibbs, Alan R.; Williams, Bryan D.; Spry, Christopher J.F. // British Medical Journal (Clinical Research Edition);8/18/1984, Vol. 289 Issue 6442, p400 

    Investigates the presence of eosinophilic cation proteins in granulomas in Churg-Strauss syndrome. Classification of Churg-Strauss syndrome; Role of eosinophils in the development of heart lesions; Clinical presentation of granulomatous and vasculitic diseases.

  • Vertigo and Parinaud’s syndrome as presentation of Churg—Strauss syndrome. Plaza, G.; Yanguela, Y.; Lopez-Lafuente, J.; Linares, M.J. // Lupus;Sep2001, Vol. 10 Issue 9, p653 

    Intracranial complications are rare in Churg–Strauss syndrome (CSS). Cerebral infarctions are the most common intracranial presentation, usually after the clinical diagnosis of CSS had been established. We present a case of vertigo and Parinaud's syndrome as presentation of CSS in an...

  • A Case Report of Churg-Strauss in Asthmatic Patients Following the Discontinuation of Corticosteroids and Using Montelukast. Parsi, Abazar; Roozbeh, Fatemeh // Journal of Mazandaran University of Medical Sciences (JMUMS);Oct/Nov2011, Vol. 21 Issue 84, p153 

    Churg-Strauss is a disease with a prevalence of one to three cases per 100 thousand people. This disease is usually observed in the patients with a history of asthma being treated with steroids whose steroid therapy has been discontinued in the process. This patient was a 62-year-old woman with...

  • Montelukast.  // Reactions Weekly;6/6/2009, Issue 1255, p24 

    The article describes the case of a 37-year-old woman who developed Churg-Strauss syndrome while being treated with montelukast, a leukotriene receptor antagonist, for possible cough variant asthma. Within 1 month of treatment, the patient's cough began to deteriorate, but she developed dyspnoea...

  • Videoendoscopic Nasal Polypectomy In Churg-Strauss Syndrome: Anaesthesiological Management. Fasciolo, Alessandro; Inglese, Sonia; Farina, Paola; Baldini, Claudio // Internet Journal of Anesthesiology;2008, Vol. 18 Issue 2, p4 

    Churg-Strauss syndrome (CSS)isan allergic or autoimmune reaction to an environmental agent or drug, consisting of the allergic, the hypereosinophilic, and the vasculitic stage. Related to anesthesia, asthma and pulmonary infiltrates are adverse conditions for a general anesthesia, whereas...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics